Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 89.00
-1.00 (-1.11%)
Oct 30, 2026, 1:30 PM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.7 billion as of October 30, 2026. It is the 26,543rd most valuable company in the world and the 1,463rd biggest in Taiwan. Its market cap has decreased by 35.87% in one year.
Market Cap
2.70B
Enterprise Value
2.17B
Revenue
332.21M
Global Rank
Country Rank
#1,463 Taiwan
PE Ratio
25.12
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.70B, an increase of 83.16%. That is a compound annual growth rate of 20.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.70B | -26.33% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.37B |
| WeLeader Biomedical | 3.27B |
| Applied BioCode | 2.99B |
| Apex Biotechnology | 2.97B |
| A Plus Biotechnology | 2.54B |
| Wellell | 2.42B |
| Dynamic Medical Technologies | 2.17B |
| Medimaging Integrated Solution | 2.08B |